share_log

Benchmark Reiterates Buy on Medicine Man Technologies, Maintains $3 Price Target

Benzinga ·  Mar 30, 2023 22:35

Benchmark analyst Mike Hickey reiterates Medicine Man Technologies (OTC:SHWZ) with a Buy and maintains $3 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment